NCPA's qAM

qAM

Bang the drum: Eliminate retroactive DIR!

by NCPA | Dec 28, 2018

More than 96 percent of NCPA member pharmacy owners tell us eliminating retroactive pharmacy DIR fees is their top priority. That's exactly what provisions in a drug pricing proposed rule from CMS, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, would do. Best way to help make sure the proposed rule is finalized? Send your comments NOW to CMS in support of the proposed DIR provisions.

We've made it quick and easy for you. Just submit sample comments on retroactive DIR through our grassroots portal. It is vital that as many comments as possible are submitted prior to the Jan. 25 deadline to urge the administration to finalize their proposals concerning pharmacy price concessions. Don't wait until the last minute. Submit your comments now! (Plus: You'll find more resources and background information for engaging your patients on this issue on our resources webpage.)